{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:18:13Z","timestamp":1760015893847},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,1,6]],"date-time":"2011-01-06T00:00:00Z","timestamp":1294272000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s00431-010-1377-2","type":"journal-article","created":{"date-parts":[[2011,1,5]],"date-time":"2011-01-05T03:55:43Z","timestamp":1294199743000},"page":"285-294","source":"Crossref","is-referenced-by-count":50,"title":["Educational paper"],"prefix":"10.1007","volume":"170","author":[{"given":"Alexis","family":"Teplick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaclyn A.","family":"Biegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim E.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,1,6]]},"reference":[{"key":"1377_CR1","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/archsurg.137.6.682","volume":"137","author":"M Baghai","year":"2002","unstructured":"Baghai M, Thompson GB, Young WF Jr et al (2002) Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: a role for laparoscopic and cortical-sparing surgery. Arch Surg 137:682\u2013688","journal-title":"Arch Surg"},{"key":"1377_CR2","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1007\/s00247-005-1518-3","volume":"35","author":"M Baldisserotto","year":"2005","unstructured":"Baldisserotto M, Peletti AB, Angelo de Ara\u00fajo M et al (2005) Beckwith-Wiedemann syndrome and bilateral adrenal pheochromocytoma: sonography and MRI findings. Pediatr Radiol 35:1132\u20131134","journal-title":"Pediatr Radiol"},{"key":"1377_CR3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11154-007-9057-x","volume":"8","author":"FM Barlaskar","year":"2007","unstructured":"Barlaskar FM, Hammer GD (2007) The molecular genetics of adrenocortical carcinoma. Rev Endocr Metab Disord 8:343\u2013348","journal-title":"Rev Endocr Metab Disord"},{"key":"1377_CR4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0022-3476(98)70001-0","volume":"132","author":"JB Beckwith","year":"1998","unstructured":"Beckwith JB (1998) Children at increased risk for Wilms tumor: monitoring issues. J Pediatr 132:377\u2013379","journal-title":"J Pediatr"},{"key":"1377_CR5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.jhh.1001378","volume":"16","author":"L B\u00e9murat","year":"2002","unstructured":"B\u00e9murat L, Gosse P, Ballanger P et al (2002) Successful lapaproscopic operation of bilateral pheochromocytoma in a patient with Beckwith-Wiedemann syndrome. J Hum Hypertens 16:281\u2013284","journal-title":"J Hum Hypertens"},{"key":"1377_CR6","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jpeds.2004.08.007","volume":"145","author":"J Bliek","year":"2004","unstructured":"Bliek J, Gicquel C, Maas S et al (2004) Epigenotyping as a tool for the prediction of tumor risk and tumor type in patients with Beckwith-Wiedemann syndrome (BWS). J Pediatr 145:796\u2013799","journal-title":"J Pediatr"},{"key":"1377_CR7","first-page":"74","volume":"59","author":"JA Biegel","year":"1999","unstructured":"Biegel JA, Zhou J, Rorke LB et al (1999) Germ-line and acquired mutations of INI1 in atypical teratoid rhabdoid tumor. Cancer Res 59:74\u201379","journal-title":"Cancer Res"},{"key":"1377_CR8","first-page":"1298","volume":"54","author":"JM Birch","year":"1994","unstructured":"Birch JM, Hartley AL, Tricker KJ et al (1994) Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li\u2013Fraumeni families. Cancer Res 54:1298\u20131304","journal-title":"Cancer Res"},{"key":"1377_CR9","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1038\/sj.onc.1204621","volume":"20","author":"JM Birch","year":"2001","unstructured":"Birch JM, Alston RD, McNally RJ et al (2001) Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 20:4621\u20134628","journal-title":"Oncogene"},{"key":"1377_CR10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1399-0004.2008.01060.x","volume":"74","author":"C Boyd","year":"2008","unstructured":"Boyd C, Smith MJ, Kluwe L et al (2008) Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis. Clin Genet 74:358\u2013366","journal-title":"Clin Genet"},{"key":"1377_CR11","author":"CS Bruggers","year":"2010","unstructured":"Bruggers CS, Bleyl SB, Pysher T et al (2010) Clincopathologic comparison of familial versus sporadic atypical teratoid\/rhabdoid tumors (AT\/RT) of the central nervous system. Pediatr Blood Cancer. doi: 10.1002\/pbc.22757","journal-title":"Pediatr Blood Cancer"},{"key":"1377_CR12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2265.2009.03662.x","volume":"72","author":"J Burgess","year":"2010","unstructured":"Burgess J (2010) How should the patient with multiple endocrine neoplasia type 1 (MEN 1) be followed? Clin Endocrinol Oxf 72:13\u201316","journal-title":"Clin Endocrinol Oxf"},{"key":"1377_CR13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/(SICI)1096-911X(199903)32:3<196::AID-MPO6>3.0.CO;2-9","volume":"32","author":"PL Choyke","year":"1999","unstructured":"Choyke PL, Siegel MJ, Craft AW et al (1999) Screening for Wilms tumor in children with Beckwith-Wiedemann syndrome or idiopathic hemihypertrophy. Med Pediatr Oncol 32:196\u2013200","journal-title":"Med Pediatr Oncol"},{"key":"1377_CR14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1067\/S0022-3476(03)00306-8","volume":"143","author":"CL Clericuzio","year":"2003","unstructured":"Clericuzio CL, Chen E, McNeil DE et al (2003) Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia. J Pediatr 143:270\u2013272","journal-title":"J Pediatr"},{"key":"1377_CR15","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/cncr.23645","volume":"113","author":"PE Clark","year":"2008","unstructured":"Clark PE, Cookson MS (2008) The von Hippel-Lindau gene: turning discovery into therapy. Cancer 113:1768\u20131778","journal-title":"Cancer"},{"key":"1377_CR16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ucl.2008.07.014","volume":"35","author":"JA Coleman","year":"2008","unstructured":"Coleman JA (2008) Familial and hereditary renal cancer syndromes. Urol Clin North Am 35:563\u2013572","journal-title":"Urol Clin North Am"},{"key":"1377_CR17","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/sj.ejhg.5201463","volume":"13","author":"WN Cooper","year":"2005","unstructured":"Cooper WN, Luharia A, Evans GA et al (2005) Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome. Eur J Hum Genet 13:1025\u20131032","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"1377_CR18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/pbc.22831","volume":"56","author":"KW Eaton","year":"2011","unstructured":"Eaton KW, Tooke LS, Wainwright LM et al (2011) Spectrum of SMARCB1\/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer 56(1):7\u201315","journal-title":"Pediatr Blood Cancer"},{"key":"1377_CR19","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/jmg.37.12.921","volume":"37","author":"JR Engel","year":"2000","unstructured":"Engel JR, Smallwood A, Harper A et al (2000) Epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome. J Med Genet 37:921\u2013926","journal-title":"J Med Genet"},{"key":"1377_CR20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10689-009-9245-9","volume":"9","author":"DG Evans","year":"2010","unstructured":"Evans DG, Lunt P, Clancy T, Eeles R (2010) Childhood predictive genetic testing for Li\u2013Fraumeni syndrome. Fam Cancer 9:65\u201369","journal-title":"Fam Cancer"},{"key":"1377_CR21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1067\/mpd.2000.106217","volume":"137","author":"DB Everman","year":"2000","unstructured":"Everman DB, Shuman C, Dzolganovski B et al (2000) Serum alpha-fetoprotein levels in Beckwith-Wiedemann syndrome. J Pediatr 137:123\u2013127","journal-title":"J Pediatr"},{"key":"1377_CR22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/jnnp.2010.206532","volume":"10","author":"RE Ferner","year":"2010","unstructured":"Ferner RE (2010) The neurofibromatoses. Pract Neurol 10:82\u201393","journal-title":"Pract Neurol"},{"key":"1377_CR23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1440-1754.2007.01027.x","volume":"43","author":"M Field","year":"2007","unstructured":"Field M, Shanley S, Kirk J (2007) Inherited cancer susceptibility syndromes in paediatric practice. J Paediatr Child Health 43:219\u2013229","journal-title":"J Paediatr Child Health"},{"key":"1377_CR24","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1200\/JCO.2004.07.073","volume":"22","author":"JM Hilden","year":"2004","unstructured":"Hilden JM, Meerbaum S, Burger P et al (2004) Central nervous system atypical teratoid\/rhabdoid tumor: results of therapy in children enrolled in a registry. J Clin Oncol 22:2877\u20132884","journal-title":"J Clin Oncol"},{"key":"1377_CR25","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jnci\/90.8.606","volume":"90","author":"M Hisada","year":"1998","unstructured":"Hisada M, Garber JE, Fung CY et al (1998) Multiple primary cancers in families with Li\u2013Fraumeni syndrome. J Natl Cancer Inst 90:606\u2013611","journal-title":"J Natl Cancer Inst"},{"key":"1377_CR26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/(SICI)1096-8628(19981002)79:4<274::AID-AJMG8>3.0.CO;2-M","volume":"79","author":"HE Hoyme","year":"1998","unstructured":"Hoyme HE, Seaver LH, Jones KL et al (1998) Isolated hemihyperplasia (hemihypertrophy): report of a prospective multicenter study of the incidence of neoplasia and review. Am J Med Genet 79:274\u2013278","journal-title":"Am J Med Genet"},{"key":"1377_CR27","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/513207","volume":"80","author":"TJM Hulsebos","year":"2007","unstructured":"Hulsebos TJM, Plomp AS, Woterman RA et al (2007) Germline mutation of INI1\/SMARCB1 in familial schwannomatosis. Am J Hum Genet 80:805\u2013810","journal-title":"Am J Hum Genet"},{"key":"1377_CR28","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1086\/374567","volume":"72","author":"SJ Hwang","year":"2003","unstructured":"Hwang SJ, Lozano G, Amos CI, Strong LC (2003) Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk. Am J Hum Genet 72:975\u2013983","journal-title":"Am J Hum Genet"},{"key":"1377_CR29","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/ajmg.a.31843","volume":"143A","author":"EM Jackson","year":"2007","unstructured":"Jackson EM, Shaikh TH, Zhang F et al (2007) Atypical teratoid\/rhabdoid tumor in a patient with Beckwith-Wiedemann syndrome. Am J Med Genet A 143A:1767\u20131770","journal-title":"Am J Med Genet A"},{"key":"1377_CR30","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.ejca.2006.05.014","volume":"42","author":"P Kaatsch","year":"2006","unstructured":"Kaatsch P, Steliarova-Foucher E, Crocetti E et al (2006) Time trends of cancer incidence in European children (1978\u20131997): report from the automated childhood cancer information system project. Eur J Cancer 42:1961\u20131971","journal-title":"Eur J Cancer"},{"key":"1377_CR31","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1200\/JCO.2002.07.400","volume":"20","author":"HM Katzenstein","year":"2002","unstructured":"Katzenstein HM, London WB, Douglass E et al (2002) Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study. J Clin Oncol 20:3438\u20133444","journal-title":"J Clin Oncol"},{"key":"1377_CR32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3171\/jns.2005.102.3.0503","volume":"102","author":"HJ Kim","year":"2005","unstructured":"Kim HJ, Butman JA, Brewer C et al (2005) Tumors of the endolymphatic sac in patients with von Hippel-Lindau disease: implications for their natural history, diagnosis and treatment. J Neurosurg 102:503\u2013512","journal-title":"J Neurosurg"},{"key":"1377_CR33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ajmg.c.30064","volume":"137C","author":"P Lapunzina","year":"2005","unstructured":"Lapunzina P (2005) Risk of tumorigenesis in overgrowth syndromes: a comprehensive review. Am J Med Genet 137C:53\u201371","journal-title":"Am J Med Genet"},{"key":"1377_CR34","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1200\/JCO.2009.27.2112","volume":"28","author":"CRM Lammens","year":"2010","unstructured":"Lammens CRM, Aaronson NK, Wagner A et al (2010) Genetic testing in Li\u2013Fraumeni Syndrome: uptake and psychosocial consequences. J Clin Oncol 28:3008\u20133014","journal-title":"J Clin Oncol"},{"issue":"4","key":"1377_CR35","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10689-010-9368-z","volume":"9","author":"CRM Lammens","year":"2010","unstructured":"Lammens CRM, Bleiker EMA, Aaronson NK et al (2010) Regular surveillance for Li\u2013Fraumeni syndrome: advice, adherence and perceived benefits. Fam Cancer 9(4):647\u2013654","journal-title":"Fam Cancer"},{"key":"1377_CR36","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1001\/jama.247.19.2692","volume":"247","author":"FP Li","year":"1982","unstructured":"Li FP, Fraumeni JF (1982) Prospective study of a family cancer syndrome. JAMA 247:2692\u20132694","journal-title":"JAMA"},{"key":"1377_CR37","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","volume":"361","author":"RR Lonser","year":"2003","unstructured":"Lonser RR, Glenn GM, Walther M et al (2003) von Hippel-Lindau disease. Lancet 361:2059\u20132067","journal-title":"Lancet"},{"key":"1377_CR38","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1212\/01.WNL.0000163982.78900.AD","volume":"64","author":"M MacCollin","year":"2005","unstructured":"MacCollin M, Chiocca EA, Evans DG et al (2005) Diagnostic criteria for schwannomatosis. Neurology 64:1838\u20131845","journal-title":"Neurology"},{"key":"1377_CR39","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/qjmed\/77.2.1151","volume":"77","author":"ER Maher","year":"1990","unstructured":"Maher ER, Yates JR, Harries R et al (1990) Clinical features and natural history of von Hippel-Lindau disease. Q J Med 77:1151\u20131163","journal-title":"Q J Med"},{"key":"1377_CR40","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1001\/jama.277.18.1461","volume":"277","author":"TJ Manksi","year":"1997","unstructured":"Manksi TJ, Heffner DK, Glenn GM et al (1997) Endolymphatic sac tumors: a source of morbid hearing loss in von Hippel-Lindau disease. JAMA 277:1461\u20131466","journal-title":"JAMA"},{"key":"1377_CR41","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.299.11.1315","volume":"299","author":"S Masciari","year":"2008","unstructured":"Masciari S, Van den Abbeele AD, Diller LR (2008) F18-fluorodeoxyglucose-positron emission tomography\/computed tomography screening in Li\u2013Fraumeni syndrome. JAMA 299:1315\u20131319","journal-title":"JAMA"},{"key":"1377_CR42","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.crad.2008.10.010","volume":"64","author":"M Meister","year":"2009","unstructured":"Meister M, Choyke P, Anderson C, Patel U (2009) Radiological evaluation, management and surveillance of renal masses in Von Hippel-Lindau disease. Clin Radiol 64:589\u2013600","journal-title":"Clin Radiol"},{"key":"1377_CR43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10689-005-4522-8","volume":"5","author":"RN Moule","year":"2006","unstructured":"Moule RN, Jhavar SG, Eeles RA (2006) Genotype phenotype correlation in Li\u2013Fraumeni syndrome kindreds and its implications for management. Fam Cancer 5:129\u2013133","journal-title":"Fam Cancer"},{"key":"1377_CR44","unstructured":"NCCN (2008) The NCCN Clinical Practice Guidelines in Oncology\u2122 Li\u2013Fraumeni syndrome (Version 1.2008). \u00a9 2009 National Comprehensive Cancer Network, Inc. www.nccn.org . Accessed March 15, 2009. To view the most recent and complete version of the NCCN Guidelines, login to http:\/\/www.nccn.org"},{"key":"1377_CR45","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0022-5347(01)62509-6","volume":"160","author":"HP Neumann","year":"1998","unstructured":"Neumann HP, Bender BU, Berger DP et al (1998) Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma. J Urol 160:1248\u20131254","journal-title":"J Urol"},{"key":"1377_CR46","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1440-1827.2006.01962.x","volume":"56","author":"Y Oda","year":"2006","unstructured":"Oda Y, Tsuneyoshi M (2006) Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features. Pathol Int 56:287\u2013295","journal-title":"Pathol Int"},{"key":"1377_CR47","first-page":"6643","volume":"63","author":"M Olivier","year":"2003","unstructured":"Olivier M, Goldgar DE, Sodha N et al (2003) Li\u2013Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res 63:6643\u20136650","journal-title":"Cancer Res"},{"key":"1377_CR48","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejca.2003.06.003","volume":"40","author":"G Perilongo","year":"2004","unstructured":"Perilongo G, Shafford E, Maibach R (2004) Risk-adapted treatment for childhood hepatoblastoma. Final report of the second study of the International Society of Paediatric Oncology\u2014SIOPEL 2. Eur J Cancer 40:411\u2013421","journal-title":"Eur J Cancer"},{"key":"1377_CR49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1399-0004.2009.01281.x","volume":"77","author":"MLM Poulsen","year":"2010","unstructured":"Poulsen MLM, Budtz-J\u00f8rgensen E, Bisgaard ML (2010) Surveillance in von Hippel-Lindau disease (vHL). Clin Genet 77:49\u201359","journal-title":"Clin Genet"},{"key":"1377_CR50","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1200\/JCO.2000.18.10.2026","volume":"18","author":"MH Porteus","year":"2000","unstructured":"Porteus MH, Narkool P, Neuberg D et al (2000) Characteristics and outcome of children with Beckwith-Wiedemann syndrome and Wilms' tumor: a report from the national Wilms tumor study group. J Clin Oncol 18:2026\u20132031","journal-title":"J Clin Oncol"},{"key":"1377_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000093008","volume":"66","author":"M Priesemann","year":"2006","unstructured":"Priesemann M, Davies KM, Perry LA et al (2006) Benefits of screening in von Hippel-Lindau disease\u2014comparison of morbidity associated with initial tumours in affected parents and children. Horm Res 66:1\u20135","journal-title":"Horm Res"},{"key":"1377_CR52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1006114732613","volume":"43","author":"F Proust","year":"1999","unstructured":"Proust F, Laquerriere A, Constantin B et al (1999) Simultaneous presentation of atypical teratoid\/rhabdoid tumor in siblings. J Neuroncol 43:63\u201370","journal-title":"J Neuroncol"},{"key":"1377_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOP.0b013e3282f4249a","volume":"20","author":"A Rao","year":"2008","unstructured":"Rao A, Rothman J, Nichols KE (2008) Genetic testing and tumor surveillance for children with cancer predisposition syndromes. Curr Opin Pediatr 20:1\u20137","journal-title":"Curr Opin Pediatr"},{"key":"1377_CR54","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/onc.2009.4","volume":"28","author":"D Reisman","year":"2009","unstructured":"Reisman D, Glaros S, Thompson EA (2009) The SWI\/SNF complex and cancer. Oncogene 28:1653\u20131668","journal-title":"Oncogene"},{"key":"1377_CR55","unstructured":"Ries LAG, Smith MA, Gurney JG et al. editors (1999) Cancer incidence and survival among children and adolescents: United States SEER Program 1975\u20131995. Bethesda (MD): National Cancer Institute, SEER Program NIH Pub. No. 99\u20134649"},{"key":"1377_CR56","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3171\/jns.1996.85.1.0056","volume":"85","author":"LB Rorke","year":"1996","unstructured":"Rorke LB, Packer RJ, Biegel JA (1996) Central nervous system atypical teratoid\/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 85:56\u201365","journal-title":"J Neurosurg"},{"key":"1377_CR57","unstructured":"Schimke RN, Collins DL, Stolle CA (2009) von Hippel-Lindau syndrome. GeneReviews. http:\/\/www.ncbi.nlm.nih.gov\/bookshelf\/br.fcgi?book=gene&part=vhl . Accessed 15 July 2010"},{"key":"1377_CR58","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1086\/302639","volume":"65","author":"N S\u00e9venet","year":"1999","unstructured":"S\u00e9venet N, Sheridan E, Amram D et al (1999) Constitutional mutations of the hSNF5\/INI1 gene predispose to a variety of cancer. Am J Hum Genet 65:1342\u20131348","journal-title":"Am J Hum Genet"},{"key":"1377_CR59","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/MOP.0b013e328332c612","volume":"21","author":"TP Slavin","year":"2009","unstructured":"Slavin TP, Wiesner GL (2009) Developmental defects and childhood cancer. Curr Opin Pediatr 21:717\u2013723","journal-title":"Curr Opin Pediatr"},{"key":"1377_CR60","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/ijc.21962","volume":"119","author":"B Strahm","year":"2006","unstructured":"Strahm B, Malkin D (2006) Hereditary cancer predisposition in children: genetic basis and clinical implications. Int J Cancer 119:2001\u20132006","journal-title":"Int J Cancer"},{"key":"1377_CR61","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/jmg.2008.060152","volume":"46","author":"JJ Swensen","year":"2009","unstructured":"Swensen JJ, Keyser J, Coffin CM et al (2009) Familial occurrence of schwannomas and malignant rhabdoid tumour associated with a duplication in SMARCB1. J Med Genet 46:68\u201372","journal-title":"J Med Genet"},{"key":"1377_CR62","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1158\/0008-5472.CAN-07-2091","volume":"68","author":"U Tabori","year":"2008","unstructured":"Tabori U, Malkin D (2008) Risk stratification in cancer predisposition syndromes: lessons learned from novel molecular developments in Li\u2013Fraumeni syndrome. Cancer Res 68:2053\u20132057","journal-title":"Cancer Res"},{"key":"1377_CR63","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1440-1754.2006.00908.x","volume":"42","author":"TY Tan","year":"2006","unstructured":"Tan TY, Amor DJ (2006) Tumour surveillance in Beckwith-Wiedemann syndrome and hemihyperplasia: a critical review of the evidence and suggested guidelines for local practice. J Paediatr Child Health 42:486\u2013490","journal-title":"J Paediatr Child Health"},{"key":"1377_CR64","doi-asserted-by":"crossref","first-page":"7641","DOI":"10.1200\/JCO.2004.00.8110","volume":"23","author":"GE Tomlinson","year":"2005","unstructured":"Tomlinson GE, Breslow NE, Dome J et al (2005) Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factor. J Clin Oncol 23:7641\u20137645","journal-title":"J Clin Oncol"},{"key":"1377_CR65","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/humu.10185","volume":"21","author":"JM Varley","year":"2003","unstructured":"Varley JM (2003) Germline TP53 mutations and Li\u2013Fraumeni syndrome. Hum Mutat 21:313\u2013320","journal-title":"Hum Mutat"},{"key":"1377_CR66","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","volume":"137","author":"KH Vousden","year":"2009","unstructured":"Vousden KH, Prives C (2009) Blinded by the light: The growing complexity of p53. Cell 137:413\u2013431","journal-title":"Cell"},{"key":"1377_CR67","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1093\/hmg\/10.26.2989","volume":"10","author":"R Weksberg","year":"2001","unstructured":"Weksberg R, Nishikawa J, Caluseriu O et al (2001) Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1. Hum Mol Genet 10:2989\u20133000","journal-title":"Hum Mol Genet"},{"key":"1377_CR68","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ajmg.c.30058","volume":"137C","author":"R Weksberg","year":"2005","unstructured":"Weksberg R, Shuman C, Smith A (2005) Beckwith-Wiedemann syndrome. Am J Med Genet 137C:12\u201323","journal-title":"Am J Med Genet"},{"key":"1377_CR69","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ejhg.2009.106","volume":"18","author":"R Weksberg","year":"2010","unstructured":"Weksberg R, Shuman C, Beckwith JB (2010) Beckwith\u2013Wiedemann syndrome. Eur J Hum Genet 18:8\u201314","journal-title":"Eur J Hum Genet"},{"key":"1377_CR70","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1002\/ajmg.a.32966","volume":"149A","author":"YA Zarate","year":"2009","unstructured":"Zarate YA, Mena R, Martin LJ et al (2009) Experience with hemihyperplasia and Beckwith\u2013Wiedemann syndrome surveillance protocol. Am J Med Genet 149A:1691\u20131697","journal-title":"Am J Med Genet"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-010-1377-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-010-1377-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-010-1377-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T15:15:01Z","timestamp":1559920501000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-010-1377-2"}},"subtitle":["Screening in cancer predisposition syndromes: guidelines for the general pediatrician"],"short-title":[],"issued":{"date-parts":[[2011,1,6]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["1377"],"URL":"https:\/\/doi.org\/10.1007\/s00431-010-1377-2","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,6]]}}}